• 27 August 1981
    • journal article
    • clinical trial
    • Vol. 99, 1264-8
Abstract
Two groups of patients with endogenous eczema (n = 36) and toxic degenerative eczema (n = 80) were treated with Hametum Salbe and a control preparation. The present results indicate that Hametum Salbe is superior in effectiveness in treatment of atopic dermatitis compared to the control preparation. There was no difference in therapeutical effectiveness in the treatment of primary irritant contact dermatitis. For treatment and interval therapy as well as for long-term treatment of chronic dermatoses Hametum Salbe is a valuable dermatological preparation which can be used without any risk in long-term therapy.

This publication has 0 references indexed in Scilit: